Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
PD-L1 Immunohistochemistry in Gastric Cancer: Comparison of Combined Positive Score and Tumor Area Positivity Across 28-8, 22C3, and SP263 Assays.
JCO Precis Oncol. 2024 Jun;8:e2400230. doi: 10.1200/PO.24.00230.
JCO Precis Oncol. 2024.
PMID: 38822761
18F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer.
Cytryn SL, Pandit-Taskar N, Lumish MA, Maron SB, Gu P, Ku GY, Chou JF, Capanu M, Antoine A, Loegel D, Feder L, Philemond S, Lyashchenko SK, Lewis JS, Paroder V, Srivastava A, Tang LH, Schoder H, Janjigian YY.
Cytryn SL, et al.
J Nucl Med. 2024 May 1;65(5):722-727. doi: 10.2967/jnumed.123.267186.
J Nucl Med. 2024.
PMID: 38514081
Item in Clipboard
Immunotherapy for Resectable Locally Advanced Esophageal Carcinoma.
Fick CN, Dunne EG, Sihag S, Molena D, Cytryn SL, Janjigian YY, Wu AJ, Worrell SG, Hofstetter WL, Jones DR, Gray KD.
Fick CN, et al. Among authors: cytryn sl.
Ann Thorac Surg. 2024 Feb 24:S0003-4975(24)00125-5. doi: 10.1016/j.athoracsur.2024.02.021. Online ahead of print.
Ann Thorac Surg. 2024.
PMID: 38408631
Review.
Item in Clipboard
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.
Cytryn SL, Moy RH, Cowzer D, Shah RH, Chou JF, Joshi SS, Ku GY, Maron SB, Desai A, Yang J, Sugarman R, Rao D, Goldberg Z, Charalambous C, Lapshina M, Antoine A, Socolow F, Trivedi N, Capanu M, Gerdes H, Schattner MA, Simmons M, Lacouture ME, Paroder V, Tang LH, Shia J, Ilson DH, Solit DB, Berger MF, Janjigian YY.
Cytryn SL, et al.
Lancet Oncol. 2023 Oct;24(10):1073-1082. doi: 10.1016/S1470-2045(23)00358-3. Epub 2023 Sep 1.
Lancet Oncol. 2023.
PMID: 37666264
Clinical Trial.
Item in Clipboard
HER2 Targeting in Esophagogastric Cancer: Redefining the Landscape and Breaking Barriers.
Cytryn SL, Janjigian YY.
Cytryn SL, et al.
J Natl Compr Canc Netw. 2023 Apr;21(4):423-429. doi: 10.6004/jnccn.2023.7010.
J Natl Compr Canc Netw. 2023.
PMID: 37015333
Review.
Item in Clipboard
Cite
Cite